Johnson & Johnson JNJ 0.93% asked U.S. regulators on Thursday to authorize the emergency use of its Covid-19 vaccine, setting the stage for a potential third vaccine to become available in the U.S. Continue Reading
Britain is on a pace to give the first shot of a two-dose coronavirus vaccine to its entire population by the end of June, if it can avoid supply and Continue Reading
It should have been Europe’s finest hour. Battered by multiple waves of Covid-19, lockdowns and recession, the European Union had found a noble way to prove its raison d’être: by Continue Reading
As coronavirus infections surged around the country in early November — and as the prospect of a long, dark winter loomed — it was not clear if any of the Continue Reading
A UK trial has been launched to see if giving people different Covid vaccines for their first and second doses works as well as the current approach of using the Continue Reading
The University of Oxford research is the first to document a vaccine substantially reducing the virus’s spread. British officials said the results underscored how mass inoculations were key to ending Continue Reading
Israel extended a national lockdown on Sunday as coronavirus variants offset its vaccination drive and officials predicted a delay in a turnaround from the health and economic crisis. Highlighting Israel’s Continue Reading
The U.S. Centers for Disease Control and Prevention (CDC) issued a sweeping order late Friday requiring the use of face masks on nearly all forms of public transportation Monday as Continue Reading
BP (NYSE: BP) is launching two initiatives to support essential services and frontline workers across the UK as they ‎battle the pandemic. BP (NYSE: BP) has revealed that it is Continue Reading
Johnson & Johnson, the only major drug maker developing a single-dose vaccine for Covid, announced on Friday that its shot provided strong protection against Covid-19, potentially offering another powerful tool in Continue Reading
